Literature DB >> 2134016

Recombinant DNA virus vectors for vaccination.

B Moss1.   

Abstract

With present technology, nearly any DNA virus can be employed as an expression vector. The characteristics of such vectors are diverse and depend on the intrinsic biological properties of the parental virus. With some vectors, construction of recombinant viruses is straightforward and expression is routinely obtained. Thus far, the greatest uses of virus vectors have been for determination of the targets of humoral and cell mediated immunity, experimental animal protection studies, protein production in cultured cells, and analysis of protein function and processing. Some recombinant virus vectors are being tested as candidate live vaccines for medical and veterinary purposes; the products of others are being evaluated as subunit vaccines.

Mesh:

Substances:

Year:  1990        PMID: 2134016

Source DB:  PubMed          Journal:  Semin Immunol        ISSN: 1044-5323            Impact factor:   11.130


  3 in total

Review 1.  DNA-antiviral vaccines: new developments and approaches--a review.

Authors:  M Giese
Journal:  Virus Genes       Date:  1998       Impact factor: 2.332

2.  Isolation and Characterization of Monoclonal Antibodies Against a Virion Core Protein of Orf Virus Strain NA1/11 As Potential Diagnostic Tool for Orf Viruses.

Authors:  Xiaoping Wang; Jiafeng Zhang; Wenbo Hao; Yongzheng Peng; Hong Li; Wei Li; Ming Li; Shuhong Luo
Journal:  Monoclon Antib Immunodiagn Immunother       Date:  2015-08

3.  Development of reverse genetics systems and investigation of host response antagonism and reassortment potential for Cache Valley and Kairi viruses, two emerging orthobunyaviruses of the Americas.

Authors:  James I Dunlop; Agnieszka M Szemiel; Aitor Navarro; Gavin S Wilkie; Lily Tong; Sejal Modha; Daniel Mair; Vattipally B Sreenu; Ana Da Silva Filipe; Ping Li; Yan-Jang S Huang; Benjamin Brennan; Joseph Hughes; Dana L Vanlandingham; Stephen Higgs; Richard M Elliott; Alain Kohl
Journal:  PLoS Negl Trop Dis       Date:  2018-10-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.